These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32526880)

  • 1. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB
    Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.
    Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
    Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
    Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
    [No Abstract]   [Full Text] [Related]  

  • 5. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
    Li M; Pei J; Ma Z; Fu J; Chen F; Du S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
    Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
    Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
    Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
    Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer.
    Borges GSM; Silva JO; Fernandes RS; de Souza ÂM; Cassali GD; Yoshida MI; Leite EA; de Barros ALB; Ferreira LAM
    Life Sci; 2019 Sep; 232():116678. PubMed ID: 31344429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
    Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
    Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization, cytotoxic effect and toxicity evaluation of nanostructured lipid carrier loaded with eucalyptol.
    Izham MNM; Hussin Y; Rahim NFC; Aziz MNM; Yeap SK; Rahman HS; Masarudin MJ; Mohamad NE; Abdullah R; Alitheen NB
    BMC Complement Med Ther; 2021 Oct; 21(1):254. PubMed ID: 34620132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of VEGFR1
    Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo.
    Fernandes RS; Silva JO; Seabra HA; Oliveira MS; Carregal VM; Vilela JMC; Andrade MS; Townsend DM; Colletti PM; Leite EA; Cardoso VN; Ferreira LAM; Rubello D; Barros ALB
    Biomed Pharmacother; 2018 Jul; 103():1348-1354. PubMed ID: 29864917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
    Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies.
    Farahi A; Abedini MR; Javdani H; Arzi L; Chamani E; Farhoudi R; Talebloo N; Hoshyar R
    Mol Cell Biochem; 2021 Sep; 476(9):3341-3351. PubMed ID: 33929675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
    Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
    Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic-Lipophilic Balance.
    Sun H; Meng Q; Tang S; Su J; Yin Q; Chen L; Gu W; Yu H; Zhang Z; Wang S; Li Y
    Mol Pharm; 2015 Sep; 12(9):3323-31. PubMed ID: 26220770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer.
    Baraya YS; Wong KK; Yaacob NS
    J Ethnopharmacol; 2019 Apr; 233():13-21. PubMed ID: 30594607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.